Исследование иммунохимических и биохимических свойств N-концевого фрагмента предшественника натрийуретического пептида В-типа человека

Список литературы

1. Altschul, S. F., Madden, Т. L., Schaffer, A. A., Zhang, J., Zhang, Z., Miller, W. &1.pman, D. J. 1997. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25: 3389−402.
2. Arden, К. C., Viars, C. S., Weiss, S., Argentin, S. & Nemer, M. 1995. Localization ofthe human B-type natriuretic peptide precursor (NPPB) gene to chromosome lp36. Genomics 26: 385−9.
3. Bettencourt, P., Ferreira, A., Dias, P., Castro, A., Martins, L. & Cerqueira-Gomes, M.2000. Evaluation of brain natriuretic peptide in the diagnosis of heart failure.1. Cardiology 93: 19−25.
4. Brandt, I., Lambeir, A. M., Ketelslegers, J. M., Vanderheyden, M., Scharpe, S. & De
5. Meester, I. 2006. Dipeptidyl-peptidase IV converts intact B-type natriuretic peptide into its des-SerPro form. Clin Chem 52: 82−7.
6. Campbell, D. J., Mitchelhill, К. I., Schlicht, S. M. & Booth, R. J. 2000. Plasma aminoterminal pro-brain natriuretic peptide: a novel approach to the diagnosis of cardiac dysfunction. J Card Fail 6: 130−9.
7. Chan, J. C., Knudson, O., Wu, F., Morser, J., Dole, W. P. & Wu, Q. 2005. Hypertensionin mice lacking the proatrial natriuretic peptide convertase corin. Proc Natl Acad Sci USA 102: 785−90.
8. Cheng, V., Kazanagra, R., Garcia, A., Lenert, L., Krishnaswamy, P., Gardetto, N.,
9. Clopton, P. & Maisel, A. 2001. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol 37: 386−91.
10. Chinkers, M. & Garbers, D. L. 1989. The protein kinase domain of the ANP receptor is required for signaling. Science 245: 1392−4.
11. Cortes, R., Rivera, M., Salvador, A., Garcia de Burgos, F., Bertomeu, V., Rosello-Lleti,
12. E., Martinez-Dolz, L., Paya, R., Almenar, L. & Portoles, M. 2007. Urinary B-type natriuretic peptide levels in the diagnosis and prognosis of heart failure. J Card Fail 13: 549−55.
13. Crimmins, D. L. & Kao, J. L. 2008. A glycosylated form of the human cardiac hormonepro B-type natriuretic peptide is an intrinsically unstructured monomeric protein. Arch Biochem Biophys 475: 36−41.
14. Davidson, N. C., Naas, A. A., Hanson, J. K., Kennedy, N. S., Coutie, W. J. & Struthers,
15. A. D. 1996. Comparison of atrial natriuretic peptide B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction. Am J Cardiol 77: 828−31.
16. Del Ry, S., Passino, C., Emdin, M. & Giannessi, D. 2006. C-type natriuretic peptide andheart failure. Pharmacol Res 54: 326−33.
17. Dubois, С. M., Laprise, M. H., Blanchette, F., Gentry, L. E. & Leduc, R. 1995.
18. Processing of transforming growth factor beta 1 precursor by human furin convertase. J Biol Chem 270: 10 618−24.
19. Emdin, M., Passino, C., Prontera, C., Fontana, M., Poletti, R., Gabutti, A., Mammini, C.,
20. Giannoni, A., Zyw, L., Zucchelli, G. & Clerico, A. 2007. Comparison of brain natriuretic peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure. Clin Chem 53: 1289−97.
21. Fenrick, R., Babinski, K., McNicoll, N., Therrien, M., Drouin, J. & De Lean, A. 1994.
22. Cloning and functional expression of the bovine natriuretic peptide receptor-B (natriuretic factor Rlc subtype. Mol Cell Biochem 137: 173−82.
23. Flynn, T. G., de Bold, M. L. & de Bold, A. J. 1983. The amino acid sequence of an atrialpeptide with potent diuretic and natriuretic properties. Biochem Biophys Res Commun 117: 859−65.
24. Fuat, A., Murphy, J. J., Hungin, A. P., Curry, J., Mehrzad, A. A., Hetherington, A.,
25. Johnston, J. I., Smellie, W. S., Duffy, V. & Cawley, P. 2006. The diagnostic accuracy and utility of a B-type natriuretic peptide test in a community population of patients with suspected heart failure. Br J Gen Pract 56: 327−33.
26. Gerbes, A. L., Dagnino, L., Nguyen, T. & Nemer, M. 1994. Transcription of brainnatriuretic peptide and atrial natriuretic peptide genes in human tissues. J Clin Endocrinol Metab 78:1307−11.
27. Giuliani, I., Rieunier, F., Larue, C., Delagneau, J. F., Granier, С., Pau, В., Ferriere, M.,
28. Saussine, M., Cristol, J. P., Dupuy, A. M., Merigeon, E., Merle, D. & Villard, S. 2006. Assay for measurement of intact B-type natriuretic peptide prohormone in blood. Clin Chem 52: 1054−61.
29. Gladysheva, I. P., Robinson, B. R., Houng, A. K., Kovats, T. & King, S. M. 2008. Corinis co-expressed with pro-ANP and localized on the cardiomyocyte surface in both zymogen and catalytically active forms. JMol Cell Cardiol 44: 131−42.
30. Goetze, J. P., Dahlstrom, U., Rehfeld, J. F. & Alehagen, U. 2008. Impact of Epitope
31. Specificity and Precursor Maturation in Pro-B-Type Natriuretic Peptide Measurement. Clin Chem.
32. Goetze. J. P., Jensen, G., Moller, S., Bendtsen, F., Rehfeld, J. F. & Henriksen, J. H.2006. BNP and N-terminal proBNP are both extracted in the normal kidney. Eur J Clin Invest 36: 8−15.
33. Goodfriend, T. L., Elliott, M. E. & Atlas, S. A. 1984. Actions of synthetic atrialnatriuretic factor on bovine adrenal glomerulosa. Life Sci 35: 1675−82.
34. Gustafsson, F., Steensgaard-Hansen, F., Badskjaer, J., Poulsen. A. H., Corell. P. &
35. Hildebrandt, P. 2005. Diagnostic and prognostic performance of N-terminal ProBNP in primary care patients with suspected heart failure. J Card Fail 11: SI 5−20.
36. Hammerer-Lercher, A., Fersterer, J., Holzmann, S., Bonatti, J., Ruttmann, E., Hoefer, D.,
37. Mair, J. & Puschendorf, B. 2006. Direct comparison of relaxation and cGMP production in human coronary by-pass grafts in response to stimulation with natriuretic peptides and a nitric oxide donor. Clin Sci (bond) 111: 225−31.
38. Hammerer-Lercher, A., Neubauer, E., Muller, S., Pachinger, O., Puschendorf, B. & Mair,
39. J. 2001. Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction. Clin ChimActa 310: 193−7.
40. Hanford, D. S., Thuerauf, D. J., Murray, S. F. & Glembotski, С. C. 1994. Brainnatriuretic peptide is induced by alpha 1-adrenergic agonists as a primary response gene in cultured rat cardiac myocytes. J Biol Chem 269: 26 227−33.
41. Harris, P. J., Thomas, D. & Morgan, Т. O. 1987. Atrial natriuretic peptide inhibits angiotensin-stimulated proximal tubular sodium and water reabsorption. Nature 326: 697−8.
42. Hashiguchi, Т., Higuchi, K., Ohashi, M., Minamino, N., Kangawa, K., Matsuo, H. &
43. Nawata, H. 1988. Porcine brain natriuretic peptide, another modulator of bovine adrenocortical steroidogenesis. FEBSLett 236: 455−61.
44. He, X. 1., Chow, D. c., Martick, M. M. & Garcia, К. C. 2001. Allosteric activation of aspring-loaded natriuretic peptide receptor dimer by hormone. Science 293: 165 762.
45. Hermanson, G. 1996. Bioconjugate techniques. Academic press Inc.
46. Heublein, D. M., Huntley, В. K., Boerrigter, G" Cataliotti, A., Sandberg, S. M., Redfield,
47. M. M. & Burnett, J. C. Jr 2007. Immunoreactivity and guanosine 3', 5'-cyclic monophosphate activating actions of various molecular forms of human B-type natriuretic peptide. Hypertension 49: 1114−9.
48. Hino, J., Tateyama, H., Minamino, N., Kangawa, K. & Matsuo, H. 1990. Isolation andidentification of human brain natriuretic peptides in cardiac atrium. Biochem Biophys Res Commun 167: 693−700.
49. Hirata, Y., Shichiri, M., Emori, Т., Marumo, F., Kangawa, K. & Matsuo, H. 1988. Brainnatriuretic peptide interacts with atrial natriuretic peptide receptor in cultured rat vascular smooth muscle cells. FEBS Lett 238: 415−8.
50. Hughes, D., Talwar, S., Squire, I. В., Davies, J. E. & Ng, L. L. 1999. Animmunoluminometric assay for N-terminal pro-brain natriuretic peptide: development of a test for left ventricular dysfunction. Clin Sci (Lond) 96: 373−80.
51. Hunt, P. J., Espiner, E. A., Nicholls, M. G., Richards, A. M. & Yandle, T. G. 1996.
52. Differing biological effects of equimolar atrial and brain natriuretic peptide infusions in normal man. J Clin Endocrinol Me tab 81: 3871−6.
53. Hunt, P. J., Espiner, E. A., Nicholls, M. G., Richards, A. M. & Yandle, T. G. 1997a. Therole of the circulation in processing pro-brain natriuretic peptide (proBNP) to amino-terminal BNP and BNP-32. Peptides 18: 1475−81.
54. Hunt, P. J., Richards, A. M., Nicholls, M. G., Yandle, T. G., Doughty, R. N. & Espiner,
55. E. A. 1997b. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment. Clin Endocrinol (Oxf) 47: 28 796.
56. Hunt, P. J. Yandle, T. G., Nicholls, M. G., Richards, A. M. & Espiner, E. A. 1995. Theamino-terminal portion of pro-brain natriuretic peptide (Pro-BNP) circulates in human plasma. Biochem Biophys Res Commun 214: 1175−83.
57. Itoh, H., Nakao, K., Mukoyama, M., Saito, Y., Yamada, Т., Shirakami, G., Arai, H.,
58. Hosoda, K., Suga, S., Yoshida, I. & et, a. 1. 1990. Preparation of monoclonal antibodies against brain natriuretic peptide and their application to radioimmunoassay and passive immunization. Endocrinology 127: 1292−300.
59. Januzzi, J. L., van Kimmenade, R., Lainchbury, J., Bayes-Genis, A., Ordonez-Llanos, J.,
60. Januzzi, J. L. Jr, Camargo, C. A., Anwaruddin, S., Baggish, A. L., Chen, A. A., Krauser,
61. Jensen, К. Т., Carstens, J. & Pedersen, E. B. 1998. Effect of BNP on renalhemodynamics, tubular function and vasoactive hormones in humans. Am J Physiol 21 A: F63−72.
62. Jewett, J. R., Koller, K. J., Goeddel, D. V. & Lowe, D. G. 1993. Hormonal induction oflow affinity receptor guanylyl cyclase. EMBOJX 2: 769−77.
63. Jourdain, P., Jondeau, G., Funck, F., Gueffet, P., Le Helloco, A., Donal, E., Aupetit, J. F.,
64. Aumont, M. C., Galinier, M., Eicher, J. C., Cohen-Solal, A. & Juilliere, Y. 2007. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study. J Am Coll Cardiol 49: 1733−9.
65. Julenius, К., Molgaard, A., Gupta, R. & Brunak, S. 2005. Prediction, conservationanalysis, and structural characterization of mammalian mucin-type O-glycosylation sites. Glycobiology 15: 153−64.
66. Karl, J., Borgya, A., Gallusser, A., Huber, E., Krueger, K., Rollinger, W. & Schenk, J.1999. Development of a novel, N-terminal-proBNP (NT-proBNP) assay with a low detection limit. Scand J Clin Lab Invest Suppl 230: 177−81.
67. Kearney, M. T. & Marber, M. 2004. Trends in incidence and prognosis of heart failure-
68. You always pass failure on the way to success. Eur Heart J25: 283−4.
69. Kilic, A., Bubikat, A., Gassner, В., Baba, H. A. & Kuhn, M. 2007. Local actions of atrialnatriuretic peptide counteract angiotensin II stimulated cardiac remodeling. Endocrinology 148: 4162−9.
70. Kimura, K., Yamaguchi, Y., Horii, M., Kawata, H., Yamamoto, H" Uemura, S. & Saito,
71. Y. 2007. ANP is cleared much faster than BNP in patients with congestive heart failure. Eur J Clin Pharmacol 63: 699−702.
72. Kishimoto, I., Dubois, S. K. & Garbers, D. L. 1996. The heart communicates with thekidney exclusively through the guanylyl cyclase-A receptor: acute handling of sodium and water in response to volume expansion. Proc Natl Acad Sci US A 93: 6215−9.
73. Knappe, S. Wu, F., Masikat, M. R., Morser, J. & Wu, Q. 2003. Functional analysis ofthe transmembrane domain and activation cleavage of human corin: design and characterization of a soluble corin. J Biol Chem 278: 52 363−70.
74. Kohler, G. & Milstein, C. 1975. Continuous cultures of fused cells secreting antibody ofpredefined specificity. Nature 256: 495−7.
75. Kudo, T. & Baird, A. 1984−1985. Inhibition of aldosterone production in the adrenalglomerulosa by atrial natriuretic factor. Nature 312: 756−7.
76. Kuhn, M. 2003. Structure, regulation, and function of mammalian membrane guanylylcyclase receptors, with a focus on guanylyl cyclase-A. Circ Res 93: 700−9.
77. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head ofbacteriophage T4. Nature 227: 680−5.
78. Lam, С. S., Burnett, J. C. Jr, Costello-Boerrigter, L., Rodeheffer, R. J. & Redfield, M. M.2007. Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population. J Am Coll Cardiol 49: 1193−202.
79. Lang, С. C., Prasad, N., McAlpine, H. M., Macleod, C., Lipworth, B. J., MacDonald, T.
80. M. & Struthers, A. D. 1994. Increased plasma levels of brain natriuretic peptide in patients with isolated diastolic dysfunction. Am HeartJXTJ: 1635−6.
81. LaPointe, M. C. 2005. Molecular regulation of the brain natriuretic peptide gene.1. Peptides 26: 944−56.
82. Latini, R., Masson, S., Anand, I., Salio, M., Hester, A., Judd, D., Barlera, S., Maggioni,
83. A. P., Tognoni, G. & Cohn, J. N. 2004. The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT. Eur Heart J 25: 292−9.
84. Light, D. В., Corbin, J. D. & Stanton, B. A. 1990. Dual ion-channel regulation by cyclic
85. GMP and cyclic GMP-dependent protein kinase. Nature 344: 336−9.
86. Lopez, M. J., Garbers, D. L. & Kuhn, M. 1997. The guanylyl cyclase-deficient mousedefines differential pathways of natriuretic peptide signaling. J Biol Chem 272: 23 064−8.
87. Lowe, D. G. 1992. Human natriuretic peptide receptor-A guanylyl cyclase is selfassociated prior to hormone binding. Biochemistry 31: 10 421−5.
88. Lowe, D. G., Camerato, T. R. & Goeddel, D. V. 1990. cDNA sequence of the humanatrial natriuretic peptide clearance receptor. Nucleic Acids Res 18: 3412.
89. Lowe, D. G., Chang, M. S., Hellmiss, R., Chen, E., Singh, S., Garbers, D. L. & Goeddel,
90. D. V. 1989. Human atrial natriuretic peptide receptor defines a new paradigm for second messenger signal transduction. EMBOJ 8: 1377−84.
91. Maack, Т., Marion, D. N., Camargo, M. J., Kleinert, H. D., Laragh, J. H., Vaughan, E. D.
92. Jr & Atlas, S. A. 1984. Effects of auriculin (atrial natriuretic factor) on blood pressure, renal function, and the renin-aldosterone system in dogs. Am J Med 77: 1069−75.
93. Maisel, A. S., Krishnaswamy, P., Nowak, R. M., McCord, J., Hollander, J. E., Due, P.,
94. Marin-Grez, M., Fleming, J. T. & Steinhausen, M. 1986. Atrial natriuretic peptide causespre-glomerular vasodilatation and post-glomerular vasoconstriction in rat kidney. Nature 324: 473−6.
95. Marttila, M., Hautala, N., Paradis, P., Toth, M., Vuolteenaho, O., Nemer, M. &
96. Ruskoaho, H. 2001. GATA4 mediates activation of the B-type natriuretic peptide gene expression in response to hemodynamic stress. Endocrinology 142: 4 693 700.
97. Masson, S., Latini, R" Anand, I. S., Vago, Т., Angelici, L., Barlera, S., Missov, E. D.,
98. Michielsen, E. C., Bakker, J. A., Kimmenade, R. R., Pinto, Y. M. & Dieijen-Visser, M. P.2008. The diagnostic value of serum and urinary NT-proBNP for heart failure. Ann Clin Biochem 45: 389−94.
99. Minamino, N., Aburaya, M., Ueda, S., Kangawa, K. & Matsuo, H. 1988. The presenceof brain natriuretic peptide of 12,000 daltons in porcine heart. Biochem Biophys Res Commun 155: 740−6.
100. Miyagi, M. & Misono, K. S. 2000. Disulfide bond structure of the atrial natriureticpeptide receptor extracellular domain: conserved disulfide bonds among guanylate cyclase-coupled receptors. Biochim Biophys Acta 1478: 30−8.
101. Miyagi, M., Zhang, X. & Misono, К. S. 2000. Glycosylation sites in the atrial natriuretic peptide receptor: oligosaccharide structures are not required for hormone binding. Eur JBiochem 267: 5758−68.
102. Molloy, S. S., Bresnahan, P. A., Leppla, S. H., Klimpel, K. R. & Thomas, G. 1992.
103. Human furin is a calcium-dependent serine endoprotease that recognizes the sequence Arg-X-X-Arg and efficiently cleaves anthrax toxin protective antigen. J Biol Chem 267: 16 396−402.
104. Mosterd, A. & Hoes, A. W. 2007. Clinical epidemiology of heart failure. Heart 93:1137−46.
105. Mueller, Т., Gegenhuber, A., Poelz, W. & Haltmayer, M. 2003. Comparison of the
106. Biomedica NT-proBNP enzyme immunoassay and the Roche NT-proBNP chemiluminescence immunoassay: implications for the prediction of symptomatic and asymptomatic structural heart disease. Clin Chem 49: 976−9.
107. Mueller, Т., Gegenhuber, A., Poelz, W. & Haltmayer, M. 2005. Diagnostic accuracy of
108. В type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure. Heart 91: 606−12.
109. Mukoyama, M., Nakao, K., Hosoda, K., Suga, S., Saito, Y., Ogawa, Y., Shirakami, G.,
110. Nakagawa, O., Ogawa, Y., Itoh, H., Suga, S., Komatsu, Y., Kishimoto, I., Nishino, K.,
111. Nussenzveig, D. R., Lewicki, J. A. & Maack, T. 1990. Cellular mechanisms of theclearance function of type С receptors of atrial natriuretic factor. J Biol Chem 265: 20 952−8.
112. Ogawa, Y., Itoh, H., Tamura, N., Suga, S., Yoshimasa, Т., Uehira, M., Matsuda, S.,
113. Shiono, S., Nishimoto, H. & Nakao, K. 1994. Molecular cloning of the complementary DNA and gene that encode mouse brain natriuretic peptide and generation of transgenic mice that overexpress the brain natriuretic peptide gene. J Clin Invest 93: 1911−21.
114. Ogawa, Y., Nakao, K., Mukoyama, M., Hosoda, K., Shirakami, G., Arai, H., Saito, Y.,
115. Suga, S., Jougasaki, M. & Imura, H. 1991. Natriuretic peptides as cardiac hormones in normotensive and spontaneously hypertensive rats. The ventricle is a major site of synthesis and secretion of brain natriuretic peptide. С ire Res 69: 491−500.
116. Ogawa, Y., Tamura, N.- Chusho, H. & Nakao, K. 2001. Brain natriuretic peptide appearsto act locally as an antifibrotic factor in the heart. Con J Physiol Pharmacol 79: 723−9.
117. Okumura, K. Yasue, H., Fujii, H., Kugiyama, K., Matsuyama, K., Yoshimura, M.,
118. Oliver, P. M., Fox, J. E., Kim, R., Rockman, H. А., Клт, H. S., Reddick, R. L., Pandey,
119. K. N., Milgram, S. L., Smithies, O. & Maeda, N. 1997. Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. Proc Natl Acad Sci USA 94: 14 730−5.
120. Omland, Т., Persson, A., Ng, L., O’Brien, R., Karlsson, Т., Herlitz, J., Hartford, M. &
121. Caidahl, K. 2002. N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation 106: 2913−8.
122. Ozaki, J., Shimizu, H., Hashimoto, Y., Itoh, H., Nakao, K. & Inui, K. 1999. Enzymaticinactivation of major circulating forms of atrial and brain natriuretic peptides. Eur J Pharmacol 370: 307−12.
123. Pankow, K., Wang, Y., Gembardt, F., Krause, E., Sun, X., Krause, G., Schultheiss, H. P.,
124. Siems, W. E. & Walther, T. 2007. Successive action of meprin A and neprilysin catabolizes B-type natriuretic peptide. Circ Res 101: 875−82.
125. Pemberton, С. J., Johnson, M. L., Yandle, T. G. & Espiner, E. A. 2000. Deconvolution analysis of cardiac natriuretic peptides during acute volume overload. Hypertension 36: 355−9.
126. Pemberton, C. J., Yandle, T. G., Charles, C. J., Rademaker, M. Т., Aitken, G. D. &
127. Espiner, E. A. 1997. Ovine brain natriuretic peptide in cardiac tissues and plasma: effects of cardiac hypertrophy and heart failure on tissue concentration and molecular forms. J Endocrinol 155: 541−50.
128. Pidgeon, G. В., Richards, A. M., Nicholls, M. G., Espiner, E. A., Yandle, T. G. &
129. Frampton, C. 1996. Differing metabolism and bioactivity of atrial and brain natriuretic peptides in essential hypertension. Hypertension 27: 906−13.
130. Pikkarainen, S., Tokola, H., Majalahti-Palviainen, Т., Kerkela, R., Hautala, N. Bhalla, S.
131. S., Charron, F., Nemer, M., Vuolteenaho, O. & Ruskoaho, H. 2003. GATA-4 is a nuclear mediator of mechanical stretch-activated hypertrophic program. J Biol Chem 278: 23 807−16.
132. Porter, J. G., Arfsten, A., Palisi, Т., Scarborough, R. M., Lewicki, J. A. & Seilhamer, J. J.1989. Cloning of a cDNA encoding porcine brain natriuretic peptide. J Biol Chem 264: 6689−92.
133. Potter, L. R., Abbey-Hosch, S. & Dickey, D. M. 2006. Natriuretic peptides, theirreceptors, and cyclic guanosine monophosphate-dependent signaling functions. EndocrRev 27: 47−72.
134. Potter, L. R. & Hunter, T. 2001. Guanylyl cyclase-linked natriuretic peptide receptors: structure and regulation. J Biol Chem 276: 6057−60.
135. Rademaker, G. J. Pergantis, S. A., Blok-Tip, L. Langridge, J. I., Kleen, A. & Thomas
136. Oates, J. E. 1998. Mass spectrometric determination of the sites of O-glycan attachment with low picomolar sensitivity. Anal Biochem 257: 149−60.
137. Rademaker, M. Т., Charles, C. J., Kosoglou, Т., Protter, A. A., Espiner, E. A., Nicholls,
138. M. G. & Richards, A. M. 1997. Clearance receptors and endopeptidase: equal role in natriuretic peptide metabolism in heart failure. Am J Physiol 273: H2372−9.
139. Rosenkranz, A. C., Woods, R. L., Dusting, G. J. & Ritchie, R. H. 2003. Antihypertrophicactions of the natriuretic peptides in adult rat cardiomyocytes: importance of cyclic GMP. Cardiovasc Res 57: 515−22.
140. Rutten, J. H., Boomsma, F. & van den Meiracker, A. H. 2006. Higher renal extraction of
141. ANP compared with NT-proANP, BNP and NT-proBNP. Eur J Clin Invest 36: 514−5.
142. Sawada, Y., Inoue, M., Kanda, Т., Sakamaki, Т., Tanaka, S., Minamino, N., Nagai, R. &
143. Takeuchi, T. 1997. Co-elevation of brain natriuretic peptide and proprotein-processing endoprotease furin after myocardial infarction in rats. FEBS Lett 400: 177−82.
144. Scarborough, R. M., Schenk, D. В., McEnroe, G. A., Arfsten, A. Kang, L. L., Schwartz,
145. K. & Lewicki, J. A. 1986. Truncated atrial natriuretic peptide analogs. Comparison between receptor binding and stimulation of cyclic GMP accumulation in cultured vascular smooth muscle cells. J Biol Chem 261: 129 604.
146. Schagger, H. & von Jagow, G. 1987. Tricine-sodium dodecyl sulfate-polyacrylamide gelelectrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal BiochetJ2 166: 368−79.
147. Schellenberger, U., O’Rear, J., Guzzetta, A., Jue, R. A., Protter, A. A. & Pollitt, N. S.2006. The precursor to B-type natriuretic peptide is an O-linked glycoprotein. Arch Biochem Biophys 451: 160−6.
148. Schiller, P. W., Maziak, L., Nguyen, Т. M., Godin, J., Garcia, R., De Lean, A. & Cantin,
149. M. 1985. Synthesis and biological activity of a linear fragment of the atrial natriuretic factor (ANF). Biochem Biophys Res Commiin 131: 1056−62.
150. Schirger, J. A., Heublein, D. M., Chen, H. H., Lisy, O., Jougasaki, M., Wennberg, P. W.
151. Burnett, J. C. Jr 1999. Presence of Dendroaspis natriuretic peptide-like immunoreactivity in human plasma and its increase during human heart failure. Mayo Clin Proc 74: 126−30.
152. Schoenfeld, J. R., Sehl, P., Quan, C., Burnier, J. P. & Lowe, D. G. 1995. Agonistselectivity for three species of natriuretic peptide receptor-A. Mol Pharmacol 47: 172−80.
153. Schoenfeld, J. R., Tom, J. Y. & Lowe, D. G. 1997. Mutations in B-type natriuretic peptide mediating receptor-A selectivity. FEBS Lett 414: 263−7.
154. Seferian, K. R., Tamm, N. N., Semenov, A. G., Mukharyamova, K. S., Tolstaya, A. A.,
155. Seidler, Т., Pemberton, C., Yandle, Т., Espiner, E., Nicholls, G. & Richards, M. 1999.
156. The amino terminal regions of proBNP and proANP oligomerise through leucine zipper-like coiled-coil motifs. Biochem Biophys Res Commun 255: 495−501.
157. Seilhamer, J. J., Arfsten, A., Miller, J. A., Lundquist, P., Scarborough, R. M., Lewicki, J.
158. A. & Porter, J. G. 1989. Human and canine gene homologs of porcine brain natriuretic peptide. Biochem Biophys Res Commun 165: 650−8.
159. Semenov, A. G., Postnikov, А. В., Tamm, N. N., Seferian, K. R., Karpova, N. S.,
160. Bloshchitsyna, M. N., Koshkina, E. V., Krasnoselsky, M. I., Serebryanaya, D. V. & Katrukha, A. G. 2009. Processing of pro-brain natriuretic peptide is suppressed by O-glycosylation in the region close to the cleavage site. Clin Chem 55: 489−98.
161. Shimekake, Y., Kawabata, Т., Nakamura, M. & Nagata, K. 1992. The role of the Cterminal region of rat brain natriuretic peptide in receptor selectivity. FEBS Lett 309: 185−9.
162. Shimizu, H., Masuta, К., Aono, K., Asada, H., Sasakura, K., Tamaki, M., Sugita, K. &
163. Yamada, K. 2002. Molecular forms of human brain natriuretic peptide in plasma. Clin Chim Acta 316: 129−35.
164. Shimizu, H., Masuta, K., Asada, H., Sugita, K. & Sairenji, T. 2003. Characterization ofmolecular forms of probrain natriuretic peptide in human plasma. Clin Chim Acta 334:233−9.
165. Song, D. L., Kohse, K. P. & Murad, F. 1988. Brain natriuretic factor. Augmentation ofcellular cyclic GMP, activation of particulate guanylate cyclase and receptor binding. FEBS Lett 232: 125−9.
166. Steg, P. G., Joubin, L., McCord, J-, Abraham, W. Т., Hollander, J. E., Omland, Т.,
167. Mentre, F., McCullough, P. A. & Maisel, A. S. 2005. B-type natriuretic peptide and echocardiography determination of ejection fraction in the diagnosis of congestive heart failure in patients with acute dyspnea. Chest 128: 21−9.
168. Stingo, A. J., Clavell, A. L., Heublein, D. M., Wei, С. M., Pittelkow, M. R. & Burnett, J.
169. C. Jr 1992. Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma. Am J Physiol 263: H1318−21.
170. Sudoh, Т., Kangawa, K., Minamino, N. & Matsuo, H. 1988. A new natriuretic peptide inporcine brain. Nature 332: 78−81.
171. Sudoh, Т., Maekawa, K., Kojima, M., Minamino, N., Kangawa, K. & Matsuo, H. 1989.
172. Cloning and sequence analysis of cDNA encoding a precursor for human brain natriuretic peptide. Biochem Biophys Res Commun 159: 1427−34.
173. Sudoh, Т., Minamino, N., Kangawa, K. & Matsuo, H. 1990. C-type natriuretic peptide
174. CNP): a new member of natriuretic peptide family identified in porcine brain. Biochem Biophys Res Commun 168: 863−70.
175. Suga, S., Nakao, K., Hosoda, K., Mukoyama, M., Ogawa, Y., Shirakami, G., Arai, H.,
176. Saito, Y., Kambayashi, Y., Inouye, K. & et, a. 1. 1992. Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology 130: 229−39.
177. Takahashi, N., Saito, Y., Kuwahara, K., Harada, M., Kishimoto, I., Ogawa, Y.,
178. Talwar, S., Squire, I. В., Davies, J. E., Barnett, D. B. & Ng, L. L. 1999. Plasma Nterminal pro-brain natriuretic peptide and the ECG in the assessment of left-ventricular systolic dysfunction in a high risk population. Eur Heart J 20: 173 644.
179. Tamura, N., Ogawa, Y., Chusho, H., Nakamura, K., Nakao, K., Suda, M., Kasahara, M.,
180. Hashimoto, R., Katsuura, G., Mukoyama, M., Itoh, H., Saito, Y., Tanaka, I., Otani, H. & Katsuki, M. 2000. Cardiac fibrosis in mice lacking brain natriureticpeptide. Proc Natl Acad Sci USA 97: 4239−44.
181. Tateyama, H., Hino, J., Minamino, N., Kangawa, K., Minamino, Т., Sakai, K., Ogihara,
182. T. & Matsuo, H. 1992. Concentrations and molecular forms of human brain natriuretic peptide in plasma. Biochem Biophys Res Commun 185: 760−7.
183. Thuerauf, D. J. & Glembotski, С. C. 1997. Differential effects of protein kinase C, Ras, and Raf-1 kinase on the induction of the cardiac B-type natriuretic peptide gene through a critical promoter-proximal M-CAT element. J Biol Chem 272: 7464−72.
184. Thuerauf, D. J., Hanford, D. S. & Glembotski, С. C. 1994. Regulation of rat brainnatriuretic peptide transcription. A potential role for GATA-related transcription factors in myocardial cell gene expression. J Biol Chem 269: 17 772−5.
185. Togashi, K., Fujita, S. & Kawakami, M. 1992. Presence of brain natriuretic peptide inurine. Clin Chem 38: 322−3.
186. Togashi, K., Hirata, Y., Ando, K., Takei, Y., Kawakami, M. & Marumo, F. 1989. Brainnatriuretic peptide-like immunoreactivity is present in human plasma. FEBS Lett 250: 235−7.
187. Troughton, R. W., Frampton, С. M., Yandle, T. G., Espiner, E. A., Nicholls, M. G. &
188. Richards, A. M. 2000. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 355: 1126−30.
189. Structure of the dimerized hormone-binding domain of a guanylyl-cyclase-coupled receptor. Nature 406: 101−4.
190. Vanneste, Y., Pauwels, S., Lambotte, L. & Deschodt-Lanckman, M. 1990. In vivometabolism of brain natriuretic peptide in the rat involves endopeptidase 24.11 and angiotensin converting enzyme. Biochem Biophys Res Соттип 1Ъ: 265−71.
191. Varki, A., Cummings, RD., Esko, JD., Freez, HH., Hart, GW. & Etzler, ME. 2008.
192. Essentials of glycobiology. NY: Cold Spring Harbor Laboratory Press.
193. Vogt-Schaden, M., Gagelmann, M., Hock, D., Herbst, F. & Forssmann, W. G. 1989.
194. Degradation of porcine brain natriuretic peptide (pBNP-26) by endoprotease-24.11 from kidney cortical membranes. Biochem Biophys Res Commun 161: 1177−83.
195. Watanabe, Т. X., Noda, Y., Chino, N., Nishiuchi, Y., Kimura, Т., Sakakibara, S. & Imai,
196. M. 1988. Structure-activity relationships of alpha-human atrial natriuretic peptide. Eur J Pharmacol 147: 49−57.
197. Watanabe, Y., Nakajima, K., Shimamori, Y. & Fujimoto, Y. 1997. Comparison of thehydrolysis of the three types of natriuretic peptides by human kidney neutral endopeptidase 24.11. Biochem Mol Med 61: 47−51.
198. Wilson, E. M. & Сhinkers, M. 1995. Identification of sequences mediating guanylylcyclase dimerization. Biochemistry 34: 4696−701.
199. Wright, S. P., Doughty, R. N., Pearl, A., Gamble, G. D., Whalley, G. A., Walsh, H. J.,
200. Gordon, G., Bagg, W., Oxenham, H., Yandle, Т., Richards, M. & Sharpe, N. 2003. Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care: a randomized, controlled trial. J Am Coll Cardiol 42: 1793−800.
201. Wu, C., Wu, F., Pan, J., Morser, J. & Wu, Q. 2003. Furin-mediated processing of Pro-Ctype natriuretic peptide. J Biol Chem 278:25 847−52.
202. Yamamoto, K., Burnett, J. C. Jr, Jougasaki, M., Nishimura, R. A., Bailey, K. R., Saito,
203. Y., Nakao, K. & Redfield, M. M. 1996. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 28: 988−94.
204. Yan, W., Sheng, N., Seto, M., Morser, J. & Wu, Q. 1999. Corin, a mosaic transmembrane serine protease encoded by a novel cDNA from human heart. J1. Biol Chem 274: 14 926−35.
205. Yan, W., Wu, F., Morser, J. & Wu, Q. 2000. Corin, a transmembrane cardiac serineprotease, acts as a pro-atrial natriuretic peptide-converting enzyme. Proc Natl AcadSci USA 97: 8525−9.
206. Yandle, Т., Fisher, S., Espiner, E., Richards, M. & Nicholls, G. 1999. Validatingaminoterminal BNP assays: a word of caution. Lancet 353: 1068−9.
207. Yasue. H., Yoshimura, M., Sumida, H., Kikuta, K., Kugiyama, K., Jougasaki, M.,
208. Виноградов, А.А. и Ямсков, ИА. 1998. Дегликозилирование гликопротеинов.
209. Биоорганическая химия. 24: 803−815.
210. Остерман JI.A. 1985. Хроматография белков и нуклеиновых кислот. Москва: Наука.